End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 USD | +6.91% | +2.20% | -4.35% |
Feb. 25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 09 | What does the Gotham City report say about Grifols? | RE |
Financials (USD)
Sales 2022 | 47.03M | Sales 2023 | 43.13M | Capitalization | 169M |
---|---|---|---|---|---|
Net income 2022 | 7M | Net income 2023 | 6M | EV / Sales 2022 | 3.31 x |
Net cash position 2022 | 15.41M | Net cash position 2023 | 17.19M | EV / Sales 2023 | 3.53 x |
P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
27.3
x | Employees | - |
Yield 2022 |
2.27% | Yield 2023 |
-
| Free-Float | 73.92% |
1 day | +6.91% | ||
1 week | +2.20% | ||
Current month | -0.24% | ||
1 month | -0.95% | ||
3 months | +1.95% | ||
6 months | -0.48% | ||
Current year | -4.35% |
Managers | Title | Age | Since |
---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Director of Finance/CFO | - | 84-11-14 | |
Chief Tech/Sci/R&D Officer | - | 97-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20-12-31 | |
Chief Administrative Officer | 54 | 91-12-31 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4.18 | +6.91% | 13,200 |
24-04-29 | 3.91 | -4.40% | 1 |
End-of-day quote Palestine Exchange, April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-4.35% | 162M | |
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- BPC Stock